“…From the 396 patients originally enrolled in our study, 139 patients with HCV RNA levels below 1,000 IU/ml were excluded from further analysis in order to achieve reproducible findings. The genotype and subtype of the remaining 257 patients' HCV isolates were determined by the InnoLipa HCV II assay (Innogenetics, Ghent, Belgium) or by phylogenetic analysis of nucleotide sequences from the 5Ј noncoding region (4,5,19,23), following PCR amplification, as previously described (3,6). To avoid false-positive results, the recommendations of Kwok and Higuchi were strictly adhered to (13).…”